Firms
RiverVest Venture Partners
- Founded
- —
- Type
- Venture capital
Funds0
No funds on record yet.
Team
No team members on record yet.
Co-investing
ARCH Venture Partners
OncoResponse, Inc.$40M · 2021
OncoResponse, Inc.$40M · 2018-09-11
OncoResponse$40M · 2018-09-11
Canaan Partners
OncoResponse, Inc.$40M · 2021
OncoResponse, Inc.$40M · 2018-09-11
OncoResponse$40M · 2018-09-11
Redmile Group
OncoResponse, Inc.$40M · 2021
OncoResponse, Inc.$40M · 2018-09-11
OncoResponse$40M · 2018-09-11
Alexandria Venture Investments
OncoResponse, Inc.$40M · 2018-09-11
OncoResponse$40M · 2018-09-11
Qatar Investment Authority
OncoResponse, Inc.$40M · 2018-09-11
OncoResponse$40M · 2018-09-11
3B Future Health Fund
OncoResponse, Inc.$40M · 2021
AJU IB Investment
Xilio Therapeutics$95M · Unknown date
Atlas Venture
Xilio Therapeutics$95M · Unknown date
Bain Capital
Xilio Therapeutics$95M · Unknown date
Eight Roads
Engrail Therapeutics$167M · 2024-03-19
F-Prime Capital
Engrail Therapeutics$167M · 2024-03-19
Forbion
Engrail Therapeutics$167M · 2024-03-19
Foresite Capital
Engrail Therapeutics$167M · 2024-03-19
Longwood Fund
Engrail Therapeutics$167M · 2024-03-19
Magnetar Capital
OncoResponse, Inc.$40M · 2021
MRL Ventures Fund
Xilio Therapeutics$95M · Unknown date
Norwest Venture Partners
Engrail Therapeutics$167M · 2024-03-19
Pivotal Life Sciences
Engrail Therapeutics$167M · 2024-03-19
Red Tree Venture Capital
Engrail Therapeutics$167M · 2024-03-19
SV Health Investors
Xilio Therapeutics$95M · Unknown date
Ysios Capital
Engrail Therapeutics$167M · 2024-03-19